RENACER - Brain Metastasis Network

Manuel Valiente shared with the researchers at the CNIO the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance

🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication.

Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.

Everything is ready for the 5th RENACER General Assembly at the Ramón Areces Foundation! We look forward to welcoming clinicians, researchers, patient representatives, and collaborators to share the latest advances in brain metastases.

Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach - PubMed Metastasis is the process through which cancer cells break away from a primary tumor, travel through the blood or lymph system, and form new tumors in distant tissues. One of the preferred sites for…

Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence.

A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉

At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment.

🙏 Thank you for turning your generosity into science and a better future.

#EuropeanDonationDay

🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care.

At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.

AEMPS AEMPS Email Forms

🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...

Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values? | Biopreservation and Biobanking Biobanks are important resources for improving public health and individual care. Some legal frameworks can be more or less conducive to advancing the potential benefits of biobanks. The purpose of…

📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks.

A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....

🧠 Save the Date!
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3

#Oncology #RENACER

🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw

“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.

Cancer Atlas Exposures to numerous potentially modifiable risk factors for cancer vary substantially across and within countries and are often associated with socioeconomic status.

The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊

🔗 canceratlas.cancer.org

20 años de ciencia transformadora: el legado de los Premios Fundación Banco Sabadell. Coincidiendo con la edición número 20, la Fundación ha impulsado “Conversaciones con Ciencia”, que otorgan la palabra a algunos de los investigadores galardonados con el premio en las ediciones…

Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay

🔗 Full interview:

🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.

MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.

🔗 sciencedirect.com/science/arti...

The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.

📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h

At #RENACER, we support research that brings us closer to personalised treatments. This study led by Zhu et al. uses organotypic cultures to identify vulnerabilities in brain metastases. A major step forward!​

🔗 pubmed.ncbi.nlm.nih.gov/35174975/

The 2025 EACR Congress is the key meeting for cancer researchers tackling brain metastases. Topics like tumour evolution & immune evasion are vital for advancing personalised medicine. RENACER is proud to connect teams driving this progress. 🧬 🔗 2025.eacr.org

Así luchan contra el cáncer la metástasis de Pepe y de otros 400 españoles: "Los tumores llegan vivos al laboratorio" «El primer día que ves un cerebro no se te olvida», dice Guillermo Blasco mientras retira con sumo cuidado la meninge que acaba de cortar. El neurocirujano del...

We are very excited to share this article from focused on our work to treat brain metastasis. With the participation of patients, professionals, and project leaders, the article highlights the challenges of treating this disease and the progress being made.​

www.elmundo.es/ciencia-y-sa...

This year’s #NMNSymposium spotlighted key advances in #neurooncology: from single-cell tech to AI imaging and immunotherapy. Topics that resonate deeply with our work at #RENACER.​

🔗 www.nmn-society.org/program/%E2%...

🧠 At #ASCO2025, Dr Juan Manuel Sepúlveda (Hospital 12 de Octubre & #RENACER) presented early results from the CAN-201 NDG trial testing azeliragon + standard care in glioblastoma.

📄 ascopubs.org/doi/pdf/10.1...
#NeuroOncology #ClinicalResearch #TranslationalMedicine

Today on #ClinicalTrialsDay, we highlight their key role in advancing medicine. At #RENACER, we’re building the knowledge needed for future trials in brain metastases, a cancer complication still lacking effective treatments. 🧠

Brain metastases are major challengein oncology. At RENACER, we are changing this with a unique workflow to collect, analyse, and classify them. Our approachdrives better treatmentsand outcomes. Discovermore in ournew infographic!

🔗 renacerbrainmet.org/renacer/

We welcome
@hospitaldelmar.bsky.social
and Hospital Clínico Universitario de Santiago to our growing network! 🏥🧠​
With 21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care.​

🔗 renacerbrainmet.org/es/miembros-...

🧬 On #InternationalDNADay, we highlight a key challenge in oncology: the genetic diversity of tumours. At RENACER, we are working to turn these discoveries into personalised therapies.​

Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/

Research is the foundation of a healthier future. 🔬 That’s why we are working to advance the next generation of personalised medicine for brain metastases.

Learn more about our research with @valientelab! 👇

🔗 www.youtube.com/embed/1IGtva...

#WorldHealthDay

Morphological MRI features as prognostic indicators in brain metastases - Cancer Imaging Background Stereotactic radiotherapy is the preferred treatment for managing patients with fewer than five brain metastases (BMs). However, some lesions recur after irradiation. The purpose of this…

📊✨ En el #DíaInternacionalDeLasMatemáticas destacamos cómo los modelos matemáticos pueden predecir la recurrencia de metástasis cerebrales tras radioterapia. Un estudio de @molab_uclm abre la puerta a tratamientos más personalizados. ​

📖 Lee más aquí:

En la #SemanaDelCerebro reforzamos nuestro compromiso para afrontar las metástasis cerebrales de manera multidisciplinar, avanzando hacia tratamientos más efectivos y menos agresivos para mejorar la vida de los pacientes.🧠💙​

#MetástasisCerebrales #InvestigaciónOncológica

II Encuentro Investigadores Contra el Cáncer C. de Vandergoten, 1, Retiro, 28014 Madrid

📢 El II Encuentro de Investigadores Contra el Cáncer de @ContraCancerEs reúne expertos de toda España para impulsar la innovación en oncología. ¡Nuestro compañero Víctor Pérez de @molab_uclm estará allí! ¿Nos vemos? ​

📅 4 de marzo | 📍 Madrid ​

Más info 👉

🧠✨ ¡Vuelve la newsletter de RENACER! ​

Descubre los últimos avances en la investigación de metástasis cerebrales: nuevas estrategias terapéuticas, proyectos innovadores y reconocimientos a nuestra labor científica. 📩 ​

🔗 https://buff.ly/4gFKvYk

Drs. @NeiblaPriego & @valientelab's work on brain metastasis has been recognised by @ContraCancerEs as top 4 studies of the year! 🎉 They have discovered how neurons interacting with the immune system fuels metastasis. 🧠💉 ​
Read the full paper 👉 https://buff.ly/40IL11P​